Fairvalue-Calculator Fairvalue-Calculator
EN DE

IVF Hartmann Holding (VBSN) Fair Value & Analysis

Healthcare · CH · Market cap CHF 295M

PriceCHF 127.00
Fair ValueCHF 133.85
Upside+5.4%
Quality95/100
Evidence: High Range CHF 107.20 – CHF 164.47

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

IVF Hartmann Holding (VBSN) currently trades at CHF 127.00, while our model-based Fair Value estimate is CHF 133.85 — implying the stock looks roughly 5.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

IVF Hartmann Holding AG provides medical consumer goods in Switzerland and internationally. The company offers medical devices; hygiene products, body care, hair care, and breast feeding aids; and disinfectants. It also provides household items, including film products, hygiene papers, catering supplies, cleaning papers and textiles, and other household items. The company was formerly known as IVF and changed its name to IVF Hartmann Holding AG in 1993. The company was founded in 1870 and is headquartered in Neuhausen am Rheinfall, Switzerland. IVF Hartmann Holding AG operates as a subsidiary of Paul Hartmann Finance B.V.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is IVF Hartmann Holding (VBSN) undervalued?
As of Jun 24, 2026, our model estimates a fair value of CHF 133.85 versus a price of CHF 127.00 — about +5% (undervalued). Model-based estimate, not financial advice.
What is the fair value of VBSN?
Our 21-model fair value for IVF Hartmann Holding is CHF 133.85 (as of Jun 24, 2026), built from audited fundamentals. The current price is CHF 127.00.
What is the quality score of VBSN?
IVF Hartmann Holding has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.